August 21st, 2010 by JenniferKearneyStrouse in Better Health Network, Health Tips, News, Research
Tags: ACP Internist, American Journal of Obstetrics & Gynecology, Diet and Nutrition, Dietary Supplement, Dietetics, Early-Onset Preeclampsia, Food and Nutrition, Healthy Pregnancy, Nutrients, Pregnancy and Childbirth, Pregnant Women, Reuters Health, Vitamin D
No Comments »
A new study in the American Journal of Obstetrics & Gynecology reports that low levels of vitamin D may be linked to early-onset preeclampsia in pregnant women.
The trial found that the average vitamin D level in 50 pregnant women with preeclampsia was 18 ng/mL, compared with 32 ng/mL in 100 women with healthy pregnancies. No casual relationship was proven, and the study’s lead author told Reuters Health that the recommended vitamin D intake in pregnant women hasn’t changed, but the study results raise yet more questions about this much-discussed nutrient.
ACP Internist covered the pros and cons of vitamin D in its November 2009 issue. (Reuters, ACP Internist)
*This blog post was originally published at ACP Internist*
August 20th, 2010 by Steven Roy Daviss, M.D. in Better Health Network, Health Policy, Humor, News, Opinion, Research, True Stories
Tags: Addiction Medicine, Controlled Substances, Drug Abuse, Drug Control, Herbal Incense, Home Chemists, Homemade Soap, JWH-018, K2, Medical Humor, Methamphetamine, Pharmaceuticals, Poison Control, Pseudoephedrine, Red Devil Lye, Research Labs, Spice, Substance Abuse, Substance Manufacturing, Synthetic Cannabinoid
No Comments »
By ClinkShrink
There’s always something new, even in the world of substance abuse. Lately I’ve been reading a lot in the media about K2, a synthetic cannabinoid that’s being sold (and outlawed) in many states. It’s commonly mixed with herbal incense and smoked. Nicknamed “spice,” it was originally created by scientists and called JWH-018.
Apparently some states’ poison control centers have been getting calls about it due to the physical symptoms it can cause, specifically palpitations and GI problems. The part of the story that I thought was interesting was the fact that originally only 250 milligrams of the stuff was created, in an “official” research lab, but that home chemists quickly took up the experiment and it’s now a part of our national drug culture. Read more »
*This blog post was originally published at Shrink Rap*
August 20th, 2010 by Medgadget in Better Health Network, Health Tips, News
Tags: Apple, Childhood Diabetes, Children's Diabetes Education, Children's Diets, Counting Carbs With Lenny, Diabetes Management, Dietetics, Endocrinology, Food and Nutrition, Good Food Choices, Health Apps, Health Education Game For Kids, Health-Related Games, iPad, iTouch, iTunes, Juvenile Diabetes, Low-Carb Diet, Medical Apps, Medtronic, Pediatrics
No Comments »
Medtronic MiniMed has recently released a new educational game for kids and young adults that takes them through an educational tour to learn how to deal with foods when you have diabetes.
A rep for the company tells Medgadget:
Called Carb Counting with Lenny, it’s offered for free download on the Apple iTunes App Store for the iPhone, iTouch and iPad. It’s great for parents (and even adults with diabetes have enjoyed it too), as the app features a guide presenting nutritious food choices with associated serving sizes and carbohydrate values. The other key components of the app are fun, interactive games that help reinforce carb counting skills and keep children engaged. And just in case you are not fully familiar with Lenny the Lion, he is a global ambassador for children’s diabetes education.
What’s more, there’s a contest with prizes for those who can beat Lenny at the app’s carb counting games.
Link: Carb Counting with Lenny!
Contest Rules….
*This blog post was originally published at Medgadget*
August 19th, 2010 by Debra Gordon in Better Health Network, Health Policy, News, Opinion, Research
Tags: Accelerated Approval, Avastin, Bevacizumab, Breast Cancer, Cancer Drug, Cancer Research, Cancer Survival Rates, Cancer Trials, Clinical Trials, Conditional Drug Approval, Drug Approval Revoked, Drug Risk Factors, FDA, Food and Drug Administration, Healthcare reform, Metastatic Cancer, Oncology, Progressive-Free Survival, Revoking A Drug, Targeted Monoclonal Antibody, Tumor Angiogenesis, Tumor Drug
No Comments »
Time to get back up on my soap box.
Next month the FDA is supposed to consider taking the unique, first-time-ever step of revoking a drug’s indication not because it’s dangerous, but because it doesn’t work well enough to offset its risks. Never mind that it costs about $8,000 a month.
The drug is Avastin (bevacizumab), a targeted monoclonal antibody that prevents tumors from creating and maintaining their own blood supply, a process called angiogenesis. Without oxygen and nutrients from blood, tumors can’t keep growing.
Avastin is the world’s best-selling cancer drug, approved for use with chemotherapy to treat lung cancer and metastatic colorectal and breast cancer. It is also being investigated (and, likely, being prescribed off label) for numerous other cancers. The problem comes with breast cancer. Read more »
*This blog post was originally published at A Medical Writer's Musings on Medicine, Health Care, and the Writing Life*
August 19th, 2010 by Berci in Better Health Network, News, Research
Tags: Analyze Your DNA, Direct-To-Consumer Genetic Testing, DTC Genetics, Family Medical History, Genetic Information, Genetics, Heredity, Mary Carmichael, Newsweek, Science Reporting
No Comments »
Mary Carmichael of Newsweek had a great series of articles focusing on direct-to-consumer genetic testing. An excerpt:
I’ve been following DTC genetics since 2007, when wide scanning first became available to the public. Since then, a number of writers have gotten wide-scale genetic tests and expounded on the results. Indeed, I sometimes wonder if I’m the last science reporter on earth with virgin genes. (Technical virgin: My doctor gave me a cystic fibrosis carrier test when I was pregnant.) Initially, I put off getting a full-genome scan because I wasn’t sure how useful such a test would be. I had no particular reason to take one, save curiosity. I wouldn’t expect to find anything serious and potentially life-altering like the Huntington’s disease gene in my results, because my family medical history is thankfully rather boring. The data most likely to be medically relevant to me would concern the genetics of common diseases, and at the time, many comprehensive and well-designed studies of those were still getting underway. I decided to wait a few years and see how research progressed. But here I am, three years later, still unsure.
*This blog post was originally published at ScienceRoll*
